Stem Pharm, Inc

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
Stem Pharm is an early stage biotech company that has developed a platform for disease modeling and drug discovery, leveraging our unique human neural organoid technology. The neural organoid model (“brain in a dish”) is applicable to studying neuroinflammatory pathways and discovery of new therapeutic approaches in neurodegenerative diseases and brain tumors such as glioblastoma. The technology can also be used for phenotypic screening of potential therapeutics for safety and efficacy. Stem Pharm is a spin out of the University of Wisconsin and is a current Illumina Accelerator company.
Speaker
photo
CEO
Stem Pharm, Inc